TY  - JOUR
AU  - Galar, Alicia
AU  - Sánchez-Somolinos, Mar
AU  - Juárez, Miriam
AU  - Verde, Eduardo
AU  - Burillo Albizua, Almudena
AU  - Bouza Santiago, Emilio
AU  - Valerio Minero, Maricela
AU  - Muñoz García, Patricia Carmen
AU  - Cercenado Mansilla, Emilia
AU  - García González, Xandra
PY  - 2019
DO  - 10.1016/j.ijantimicag.2018.09.015
SN  - 0924-8579
UR  - https://hdl.handle.net/20.500.14352/116945
T2  - Int J Antimicrob Agents .
AB  - Therapeutic drug monitoring (TDM) could optimise daptomycin use. However, no validated serum target levels have been established. This prospective study at a tertiary centre including hospitalised patients receiving daptomycin aimed to evaluate the...
LA  - eng
M2  - 40
PB  - Elsevier
KW  - Daptomycin
KW  - Serum levels
KW  - Bacterial infection
KW  - Gram-positive bacteria
KW  - Therapeutic drug monitoring
TI  - Current use of daptomycin and systematic therapeutic drug monitoring: Clinical experience in a tertiary care institution
TY  - journal article
VL  - 53
ER  -